Company News:
Dr. Claudio Denoya Appointed to United States Pharmacopoeia Panel Colorado, -- February 08, 2016--
BOULDER, Colo., Feb. 8, 2016 /PRNewswire/ -- Dr. Claudio Denoya, Senior Scientist at Particle Measuring Systems (PMS), was recently appointed to the Modern Microbiology Methods Expert Panel of the United States Pharmacopoeia (USP) in an advisory role. The panel will make recommendations for a ne..... ...Read More »
Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference New Haven-- US -- February 08, 2016-- NEW HAVEN, Conn., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016, at 11:35 a.m. ET at the Waldorf Astoria ... ...Read More »
AGTC Announces Financial Results for the Quarter Ended December 31, 2015 Alachua-- US -- February 08, 2016--

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, with a primary focus on ophthalmology, today announced financial results for the quarter ended December 31... ...Read More »

Highspot Becomes First Sales Enablement Platform to Offer Integration with Microsoft Office Online -- February 08, 2016--

Seattle, WA (PRWEB) February 08, 2016

...Read More »

Perkins Restaurant & Bakery Remodeling Initiative on Track and Being Met With Great Success Tennessee, -- February 08, 2016--
MEMPHIS, Tenn., Feb. 8, 2016 /PRNewswire/ --Perkins Restaurant & Bakery reports that its system-wide remodeling initiative introduced in 2013 and officially rolled out in 2014, is well underway. To date a total of 69 company-operated restaur..... ...Read More »
Cancer Genetics, Inc. to Present at Source Capital Groups 2016 Disruptive Growth & Healthcare Conference Rutherford-- US -- February 08, 2016--

RUTHERFORD, N.J., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (CGI or The Company), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announces that President and CEO Panna Sharma is scheduled to present a corporate overview and participate in an industry roundtable conference at Source Capital Gro... ...Read More »

Streptococcus Pneumoniae Infection - Pipeline Market Review To 2015: Radiant Insights, Inc. -- February 06, 2016-- 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2015', provides an overview of the Streptococcus Pneumoniae Infection's therapeutic pipeline.

...Read More »

Syneron Medical to Participate in Leerink Partners 5th Annual Global Healthcare Conference California,New York, -- February 05, 2016--
IRVINE, Calif., Feb. 5, 2016 /PRNewswire/ --Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that William Griffing, Chief Executive Officer of Syneron Candela North America, is scheduled to participate in the Leerink Partners 5th Annual..... ...Read More »
Sicca Syndrome (Sjogren) - Pipeline Review, H2 2015 England, -- February 04, 2016--
LONDON, Feb. 4, 2016 /PRNewswire/ -- Sicca Syndrome (Sjogren) - Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Sicca Syndrome (Sjogren) - Pipeline Review, H2 2015', provides an overview of the Sicca Syndrome (Sjogren)'s therapeutic pipeline.

This report provides comprehensive ..... ...Read More »
Wegener Polyangiitis - Pipeline Review, H2 2015 England, -- February 04, 2016--
LONDON, Feb. 4, 2016 /PRNewswire/ -- Wegener Polyangiitis - Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Wegener Polyangiitis - Pipeline Review, H2 2015', provides an overview of the Wegener Polyangiitis's therapeutic pipeline.

This report provides comprehensive information ..... ...Read More »
Garrison Capital Inc. Schedules Earnings Release for the Fourth Quarter Ended December 31, 2015 New York-- US -- February 04, 2016--

NEW YORK, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Garrison Capital Inc., a business development company (the Company) (NASDAQ:GARS), announced today that it plans to report financi... ...Read More »

Arbutus Biopharma to Participate in Upcoming Investor Conferences Burnaby-- CA -- February 04, 2016--

VANCOUVER, British Columbia and DOYLESTOWN, Pa., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focus... ...Read More »

City National and Barnes & Noble Donate New Books and Cash Totaling Over $200,000 to Schools and Nonprofits in Four States -- US -- February 04, 2016-- LOS ANGELES, Feb. 04, 2016 (GLOBE NEWSWIRE) -- City National Banks Reading is The way up nonprofit literacy program, in partnership with Barnes & Noble, today announced the donation of  new books and cash totaling over $200,000 to 43 schools and nonprofit organizations in California, Nevada, New York C... ...Read More »
Delcath Systems to Present at Upcoming Investor Conferences New York, -- February 04, 2016--
NEW YORK, Feb. 4, 2016 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that Company management will participate at two upcoming investor conferences in February. ..... ...Read More »
VIPole Secure Messenger Launches the Revolutionary Secure Multi-User Videoconferencing With End-to-End Encryption United States of America,United Kingdom,France,Germany,Spain, -- February 04, 2016--
LONDON, February 4, 2016 /PRNewswire/ -- ...Read More »
ING 2015 underlying net profit EUR 4,219 million; FY 2015 dividend at EUR 0.65 per ordinary share Amsterdam-- NETHERLANDS -- February 03, 2016--
Think Forward strategy drives strong new customer acquisitions and commercial growth in 2015
·ING attracted over 1.4 million new retail customers; primary relationships increased by al... ...Read More »
Semi-Finalists Chosen in National Financial Plan Competition -- February 03, 2016--

Middletown, OH (PRWEB) February 03, 2016

...Read More »

Cytokinetics to Participate in Upcoming Investor Conferences South San Francisco-- US -- February 03, 2016-- SOUTH SAN FRANCISCO, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 18th Annual BIO CEO & Investor Conference on Monday, February 8, 2016 at 1:30 PM EST at the Waldorf Astoria in New York, NY. Members of Cytokinetics' senior management team... ...Read More »
Xencor to Present at Two Upcoming Conferences in February California,New York, -- February 03, 2016--
MONROVIA, Calif., Feb. 3, 2016 /PRNewswire/ --Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that company management will present a corporate overview at tw..... ...Read More »
MabVax Therapeutics to Present at BIO CEO & Investor Conference California, -- February 03, 2016--
SAN DIEGO, Feb. 3, 2016 /PRNewswire/ --MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical-stage immuno-oncology drug development company, announces that President and Chief Executive Officer David Hansen is scheduled..... ...Read More »
RSM Awarded National Champions for the European Business Awards 2015/16 United States of America,United Kingdom,France,Germany,Spain,Cyprus, -- February 03, 2016--
NICOSIA, Cyprus, February 3, 2016 /PRNewswire/ -- ...Read More »
Aduro Biotech to Present at Leerink Partners Global Healthcare Conference Berkeley-- US -- February 03, 2016-- BERKELEY, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, was invite... ...Read More »
Depomed to Present at Healthcare Conferences in February Newark-- US -- February 03, 2016-- NEWARK, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the following healthcare conferences during the month of February.
...Read More »
International Paper Reports 2015 Fourth Quarter and Full-Year Earnings Tennessee, -- February 03, 2016--
MEMPHIS, Tenn., Feb.3, 2016 /PRNewswire/ -- International Paper (NYSE: IP) today reported full-year 2015 net earnings attributable to International Paper of $938 million ($2.23 per share) compared with $555 million ($1.29 per share) in..... ...Read More »
OncoSec to Present at Prominent Investment Conferences in February California, -- February 03, 2016--
SAN DIEGO, Feb. 3, 2016 /PRNewswire/ --OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be making presentations at several high-profile events in February, including: ...Read More »
Energizer Holdings, Inc. Announces Fiscal 2016 First Quarter Results and Updates Financial Outlook for Fiscal 2016 Missouri, -- February 03, 2016--
ST. LOUIS, Feb. 3, 2016 /PRNewswire/ -- Energizer Holdings, Inc. (NYSE: ENR) today announced results for the first fiscal quarter, which ended December31, 2015. For the first fiscal quarter, net earnings were $65.5 million, or $1.05 per diluted shar..... ...Read More »
Nicox to present at the 18th Annual BIO CEO & Investor Conference Sophia Antipolis Cedex-- FRANCE -- February 03, 2016-- SOPHIA ANTIPOLIS, France, Feb. 3, 2016 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: FR0013018124, COX) today announced that Michele Garufi, Chairman and CEO of Nicox, will be presenting at the 18th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2016, at 10:00 a.m. Eastern Time. The conference is being held at The Waldorf Astoria hotel in New Yo... ...Read More »
SteadyMed to Present at 18th Annual BIO CEO & Investor Conference San Ramon-- US -- February 02, 2016--

SAN RAMON, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a pre-NDA stage specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet parenteral delivery needs, today announced that Jonathan Rigby, President and Chief Executive Officer will present at the BIO CEO conference on Tuesday, Feb... ...Read More »

Cytokinetics to Announce Fourth Quarter Results on February 16, 2016 South San Francisco-- US -- February 02, 2016-- SOUTH SAN FRANCISCO, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) announced today that it is scheduled to report fourth quarter results on Tuesday, February 16, 2016 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the compan... ...Read More »
Global Smoking Cessation Market Size, Share, Growth, Trends, Analysis To 2015: Acute Market Reports -- February 02, 2016-- Global Markets Direct's, 'Smoking Cessation - Pipeline Review, H2 2015', provides an overview of the Smoking Cessation's therapeutic pipeline.

This report pr... ...Read More »
FIX8Group Joins Roster of d3 Studios Offering Full d3 Technologies Workflow to Customers London -- February 02, 2016-- d3 Technologies is pleased to announce that FIX8Group has become a d3 Studio offering a full d3 workflow as its in-house solution for pre-production and production of live events. d3 maintains a network of partner studios around the world dedicated to helping fulfill customers' d3 requirements, from consultation and support to client demos and more. ...Read More »
Provision Issues Letter to Shareholders Chatsworth-- US -- February 02, 2016--

CHATSWORTH, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Provision Holding, Inc. (OTCQB:PVHO) announced today that it has issued a shareholder update letter from Curt Thornton, Chairman ... ...Read More »

NYMBUS Appoints Eric Isham as Chief of Business Development -- February 02, 2016--

Miami, Florida (PRWEB) February 02, 2016

...Read More »

POZEN Inc. Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc. North Carolina,Canada, -- February 02, 2016--
-Transaction Expected to Close on or About February 5, 2016- ...Read More »
Calithera Biosciences to Present at the BIO CEO & Investor and Leerink Global Healthcare Conferences in February South San Francisco-- US -- February 02, 2016-- SOUTH SAN FRANCISCO, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, today announced its participation in two investor conferences during the month of February.... ...Read More »
Viking Therapeutics to Present at Upcoming Investor Conferences California, -- February 02, 2016--
SAN DIEGO, Feb. 2, 2016 /PRNewswire/ --Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announcedthat its chief executive officer, ...Read More »
HOT THREADS on DMN Forums
Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!
Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved